BEELINE AS • 912557367 • Oslo

This website uses cookies to enhance the user experience.

||

BEELINE AS

Organization

Chairman of the board: LK
Line Knivsflå Loen1965
Years since formation: 12 years; since Oct 14, 2013
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 81,587; 1 share class
Total number of shareholders: 1; person

Financials

Annual total result 2024: -2,306,597; NOK
Total equity 2024: 45,097,074; NOK

Last update: Sep 9, 2025

Management

Board

Name	Role	Shares
LK Line Knivsflå Loen 1965	Contact Person, Chairman	100 % directly

Others

Name	Role	Shares
B BDO AS	Auditor	-
H HASUND AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
LK Line Knivsflå Loen 1965	Contact Person, Chairman	100 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
LK Line Knivsflå Loen 1965	Ordinary shares	81,587	100 %

Shares owned by the BEELINE AS

Name	Share class	Total number of shares	Share
I ISLAND OFFSHORE V AS	Ordinary shares	4,089	1.74 %
U ULSTEIN HOTELL AS	Ordinary shares	75,935	1.65 %
U ULSTEINVIK UTVIKLING AS	Ordinary shares	439	1.54 %
I ISLAND OFFSHORE XII AS	Ordinary shares	38,000	1.46 %
A ALLIANCE VENTURE POLARIS AS	Ordinary shares	62,579	1.45 %
I ISLAND OFFSHORE XI AS	Ordinary shares	3,595,295	1.35 %
I ISLAND OFFSHORE VIII AS	Ordinary shares	336,636	0.92 %
B BYGGMA ASA	NO0003087603	531,760	0.76 %
U ULSTEIN GROUP ASA	NO0010003429	4,885,488	0.74 %
A AS HOTEL ALEXANDRA	Ordinary shares	1,075	0.47 %
P PCI BIOTECH HOLDING ASA	NO0010405640	100,000	0.27 %
L LYTIX BIOPHARMA AS	NO0010405780	36,320	0.05 %
A AMICOAT AS	NO0010799679	9,720	0.03 %
P PHARMASUM THERAPEUTICS AS	Ordinary shares	916	0.03 %
P PHARMA HOLDINGS AS	NO0010797350	194	0.02 %
V VÅR ENERGI ASA	NO0011202772	56,000	< 0.01 %
P PHOTOCURE ASA	NO0010000045	894	< 0.01 %
N NORDIC HALIBUT AS	NO0003058109	160	< 0.01 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	-2,306,597	-10,696,778	529,416	7,917,954
Total assets	47,252,269	50,550,814	61,210,131	60,679,339
Total liabilities	2,155,195	3,147,143	3,150,476	3,149,100
Total equity	45,097,074	47,403,671	58,059,655	57,530,240

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	41,971	74,189	67,436	62,957
Operating result	-41,971	-74,189	-67,436	-62,957
Financial income/costs	-2,264,626	-10,622,589	596,851	7,980,911
Profit before tax	-2,306,597	-10,696,778	529,416	7,917,954
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-2,306,597	-10,696,778	529,416	7,917,954

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	15,467,836	15,028,836	15,388,598	16,013,438
Total current assets	31,784,433	35,521,978	45,821,534	44,665,901
Total assets	47,252,269	50,550,814	61,210,131	60,679,339
Short term debt	2,155,195	3,147,143	3,150,476	3,149,100
Long term debt	0	0	0	0
Total liabilities	2,155,195	3,147,143	3,150,476	3,149,100
Contributed capital	293,290	293,290	252,496	252,496
Retained earnings	44,803,785	47,110,381	57,807,159	57,277,744
Total equity	45,097,074	47,403,671	58,059,655	57,530,240
Total equity and liabilities	47,252,269	50,550,814	61,210,131	60,679,339

Classification

Type of organization

Limited company